Status:
NOT_YET_RECRUITING
Novel On-body Evaluation of Cardiac Health for Oncology
Lead Sponsor:
Skribe Medical
Collaborating Sponsors:
University of Rochester
Conditions:
Cardiotoxicity
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this study is to develop a wearable sensor system that can estimate left ventricular ejection fraction (LVEF), which is a measurement of the heart's function.
Eligibility Criteria
Inclusion
- Undergoing an echocardiogram irrespective of participation in this study
- Willing and able to provide informed consent prior to any study-related activity
Exclusion
- Have a documented allergy to potential tissue contacting system materials
- Have been diagnosed with one or more of the following cardiac diseases/conditions that distort cardiac activity:
- Severe valve disease
- Severe right ventricular dilation or dysfunction
- Significant arrhythmias or conduction abnormalities
- Active ischemia or myocardial infarction within the last 3 months
- Have an active implantable cardiac device
- Have any condition that would cause inaccurate TTE measurements
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07158450
Start Date
September 1 2025
End Date
March 1 2026
Last Update
September 11 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.